A Randomized, Placebo-Controlled Trial of Pentoxifylline on Erythropoiesis-Stimulating Agent Hyporesponsiveness in Anemic Patients With CKD: The Handling Erythropoietin Resistance With Oxpentifylline (HERO) Trial

D.W. Johnson, E.M. Pascoe, S.V. Badve, K. Dalziel, A. Cass, P. Clarke, Paolo Ferrari, S.P. Mcdonald, A.T. Morrish, E. Pedagogos, V. Perkovic, D. Reidlinger, A. Scaria, R. Walker, L.A. Vergara, C.M. Hawley

    Research output: Contribution to journalArticle

    22 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)49-57
    JournalAmerican Journal of Kidney Diseases
    Volume65
    Issue number1
    Publication statusPublished - 2014

    Cite this